Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by CravenRaven101on Dec 02, 2011 9:43am
255 Views
Post# 19286234

RE: Feeling Sorry, Part 2

RE: Feeling Sorry, Part 2MY point is far less convoluted than Singing Germini states... beyond WHAT any market regulation requires there ARE hundreds of databases and sources to acquire information on any given company... to simply rely on someone's advice (as Germini has obviously done, otherwise why concoct such paranoid drivel) and to NOT understand that the stakes are SO high that OF course unscrupulous sots will gravitate to such opportunities... IF YOU do NOT take that dynamic into account LIke Germini, you will, end up like him... tossing conspiracy "poop" against the wall hoping that someone... anyone will listen...

I understand where he is coming from... this forum gives him a sense , misguided as it may be, that he is in the lion's den... and the HE , Daniel, is actually fighting the good fight...that his voice matters..and sadly.. I have for sometime offered him his foil...

paractically speaking... I would suggest that the numbers he bandies about... the disparate trading valumes are a function of population... it would stand to reason that since our Southerly neighbours are 10X us... trade voluem ought to reflect that...does it??? and what of volume... in MY mind such LOW volume suggests to me that the majority of shres are on the sidelines waiting for the "pop"

That's where the smart money in all this would be... am I a trader? an invesmtent insider? certainly NOT I make my money at the M&A and A&D end of the O&G business...why am I here? because the ONC story is a compelling one...a story that requires patience...and a basic understanding of humanity... rather than skewed statistics.

it's MY opinion git yer own.
Bullboard Posts